PharmacoEpi and Risk Management (PRM) NewsletterThe MAPI Research Trust has created the PharmacoEpi and Risk Management (PRM) Newsletter to provide a forum for members of our community to discuss and debate issues relevant to their work. Our goal is to provide articles from members of the community broadly related to either applications of methods, development of new tools and reflections on regulatory developments. The PRM Newsletter can also be used as a vehicle for inviting commentary and previous experience on problems that you are actively working to solve. Each issue will contain an updated list of future meetings and would highlight significant publications that might be of interest to our community.
Go to www.prmnewsletter.org
New questionnaires distributed by MAPI Research Trust ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire) Novartis Pharmaceuticals Corporation (USA) FIS (Fatigue Impact Scale) D-FIS (Daily Fatigue Impact Scale)John Fisk (Canada) HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ® Abbott France (France) MOS-HIV (Medical Outcome Study-HIV Health Survey)Albert Wu (USA)MPQ (McGill Pain Questionnaire) Ronald Melzack (Canada)MPQ-SF (McGill Pain Questionnaire - Short Form) Ronald Melzack (Canada)Nausea Questionnaire Ronald Melzack (Canada)ODI (Oswestry Disability Questionnaire)Jeremy Fairbank (UK)PHQ (Patient Health Questionnaire ScreenersPfizer Inc. (USA)PRAC-Test (PRAgmatic Content and face validity Test)Mapi Values (France) SF-MPQ-2 (Short-form McGill Pain Questionnaire) Ronald Melzack (Canada) and IMMPACT (USA) To access our catalog, please click here.Coming soon!Crohn and Anti-tnf Treatment Satisfaction questionnaire Abbott France (France)For any information, please contact: contact@mapi-trust.org